Ionic Rare Earths (ASX: IXR) Advances Magnet Recycling and REE Projects
Ionic Rare Earths (ASX: IXR) reports significant progress in magnet recycling and heavy rare earth projects, reducing CO₂ emissions.
Category: Energy
Electro Optics Systems Holdings (ASX:EOS) Reports Business Turnaround and Financial Strengthening
EOS (ASX:EOS) announces significant business restructuring, portfolio divestments, and financial repayments as part of its ongoing turnaround strategy.
Aurora Labs Limited (ASX:A3D) Completes AU4 Micro Gas Turbine Development
Aurora Labs (ASX:A3D) completes development of the AU4 micro gas turbine, advancing production and defence sector engagements.
NOVONIX Limited (ASX:NVX) Finalizes Purchase of Enterprise South Land
NOVONIX Limited (ASX:NVX) finalizes a $5 million land purchase in Chattanooga, expanding production capacity and creating up to 500 jobs.
GreenTech Metals (ASX:GRE) Announces Q1 2025 Copper Drilling and Lithium Joint Venture
GreenTech Metals (ASX:GRE) reports significant copper drill results and a joint venture with Artemis to expand lithium projects in West Pilbara.
Mont Royal Resources (ASX:MRZ) Announces Merger with Commerce Resources
Mont Royal Resources (ASX:MRZ) merges with Commerce Resources to form a Canadian-focused critical metals company, enhancing its asset portfolio.
New Frontier Minerals (ASX:NFM) Reports Q1 2025 Highlights and Strategic Partnerships
New Frontier Minerals (ASX:NFM) reports Q1 2025 achievements, including exploration milestones, strategic alliance with Austral Resources, and asset sales.
Australian Rare Earths Limited (ASX:AR3) Completes $3.6M Rights Issue
Australian Rare Earths Limited (ASX:AR3) completes a $3.6M rights issue, enhancing project development and strategic positioning.
Australian Rare Earths Limited (ASX:AR3) Announces Uranium Exploration Results
Australian Rare Earths Limited (ASX:AR3) extends uranium mineralisation at Overland Project, supporting calcrete-hosted model with assay results expected soon.
Immutep Limited (ASX:IMM) Reports Q3 FY25 Milestones and Financial Position
Immutep Limited (ASX:IMM) announces significant clinical trial milestones and maintains a robust cash position in its Q3 FY25 report.